Update on rifampin drug interactions .3.

被引:57
作者
Strayhorn, VA
Baciewicz, AM
Self, TH
机构
[1] UNIV TENNESSEE,CTR HLTH SCI,DEPT CLIN PHARM,MEMPHIS,TN 38163
[2] UNIV HOSP CLEVELAND,DEPT PHARM SERV,CLEVELAND,OH 44106
关键词
D O I
10.1001/archinte.157.21.2453
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Rifampin is a potent inducer of cytochrome P-450 oxidative enzymes. Examples of well-documented, clinically significant interactions include warfarin, oral contraceptives, cyclosporine, glucocorticoids, ketoconazole, theophylline, quinidine, digitoxin, and verapamil, Recent reports have demonstrated clinically relevant interactions with protease inhibitors, zidovudine, delavirdine, itraconazole, nifedipine, midazolam or triazolam, nortriptyline, and doxycycline. To avoid reduced therapeutic response, therapeutic failure, or toxic reactions when rifampin is added to or discontinued from medication regimens, clinicians need to be cognizant of these interactions. Enhanced knowledge of known interactions will continue to develop, including research on induction of specific cytochrome P-450 isoenzymes. New rifampin interactions will be discovered with further investigations.
引用
收藏
页码:2453 / 2458
页数:6
相关论文
共 54 条
[51]  
Yuen G. J., 1997, Clinical Pharmacology and Therapeutics, V61, P147
[52]  
Zhou H.-H., 1997, Clinical Pharmacology and Therapeutics, V61, P227
[53]   MULTIPLE-DRUG INTERACTIONS WITH CYCLOSPORINE IN A HEART-TRANSPLANT PATIENT [J].
ZYLBERKATZ, E .
ANNALS OF PHARMACOTHERAPY, 1995, 29 (02) :127-131
[54]  
1997, PHYSICIANS DESK REFE, P447